ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention

NARecruitingINTERVENTIONAL
Enrollment

4,630

Participants

Timeline

Start Date

December 9, 2024

Primary Completion Date

May 1, 2027

Study Completion Date

July 1, 2027

Conditions
Papillomavirus Vaccines
Interventions
BEHAVIORAL

Brief training

Clinicians and nurses will receive a brief training. Each training will have a one-hour didactic and interactive session and follow-up practice sessions. Trainings will focus on providers presenting the HPV vaccine as safe, best if received at 9- to 12-years of age, and prevents cancer.

BEHAVIORAL

Parent-targeted motivational aids

Parents will be sent messages via text, phone, or postcard about the HPV vaccine. Parents who do not respond to messages will be offered a phone-based motivational interview session about the HPV vaccine.

BEHAVIORAL

Healthcare access

Healthcare access will involve three components coordinated by UF Health Cancer Center Community Outreach and Engagement Office: transportation assistance to a participating clinic or mobile vaccination clinic, UF mobile vaccination clinic scheduling, and connection to health insurance navigators.

Trial Locations (1)

32608

RECRUITING

University of Florida, Gainesville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Florida

OTHER